Srivastava SC - Search Results

1

Mirzadeh S, Mausner LF, Srivastava SC. Mirzadeh S, et al. Among authors: srivastava sc. Int J Rad Appl Instrum A. 1986;37(1):29-36. doi: 10.1016/0883-2889(86)90192-9. Int J Rad Appl Instrum A. 1986. PMID: 3019924

2

Radioactive gold cluster immunoconjugates: potential agents for cancer therapy.

Hainfeld JF, Foley CJ, Srivastava SC, Mausner LF, Feng NI, Meinken GE, Steplewski Z. Hainfeld JF, et al. Among authors: srivastava sc. Int J Rad Appl Instrum B. 1990;17(3):287-94. doi: 10.1016/0883-2897(90)90054-5. Int J Rad Appl Instrum B. 1990. PMID: 2341283

3

Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy.

Kolsky KL, Joshi V, Mausner LF, Srivastava SC. Kolsky KL, et al. Among authors: srivastava sc. Appl Radiat Isot. 1998 Dec;49(12):1541-9. doi: 10.1016/s0969-8043(98)00016-5. Appl Radiat Isot. 1998. PMID: 9745690

4

Development of a large scale production of 67Cu from 68Zn at the high energy proton accelerator: closing the 68Zn cycle.

Medvedev DG, Mausner LF, Meinken GE, Kurczak SO, Schnakenberg H, Dodge CJ, Korach EM, Srivastava SC. Medvedev DG, et al. Among authors: srivastava sc. Appl Radiat Isot. 2012 Mar;70(3):423-9. doi: 10.1016/j.apradiso.2011.10.007. Epub 2011 Oct 20. Appl Radiat Isot. 2012. PMID: 22142633

5

Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2.

DeNardo GL, Kukis DL, DeNardo SJ, Shen S, Mausner LF, O'Donnell RT, Lamborn KR, Meyers FJ, Srivastava SC, Miers LA. DeNardo GL, et al. Among authors: srivastava sc. Cancer. 1997 Dec 15;80(12 Suppl):2576-82. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2576::aid-cncr33>3.3.co;2-3. Cancer. 1997. PMID: 9406712

6

Radionuclide development at BNL for nuclear medicine therapy.

Mausner LF, Kolsky KL, Joshi V, Srivastava SC. Mausner LF, et al. Among authors: srivastava sc. Appl Radiat Isot. 1998 Apr;49(4):285-94. doi: 10.1016/s0969-8043(97)00040-7. Appl Radiat Isot. 1998. PMID: 9519438 Review.

7

Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.

Denardo GL, Denardo SJ, Kukis DL, O'Donnell RT, Shen S, Goldstein DS, Kroger LA, Salako Q, Denardo DA, Mirick GR, Mausner LF, Srivastava SC, Meares CF. Denardo GL, et al. Among authors: srivastava sc. Anticancer Res. 1998 Jul-Aug;18(4B):2779-88. Anticancer Res. 1998. PMID: 9713461 Clinical Trial.

8

67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.

DeNardo SJ, DeNardo GL, Kukis DL, Shen S, Kroger LA, DeNardo DA, Goldstein DS, Mirick GR, Salako Q, Mausner LF, Srivastava SC, Meares CF. DeNardo SJ, et al. Among authors: srivastava sc. J Nucl Med. 1999 Feb;40(2):302-10. J Nucl Med. 1999. PMID: 10025839 Free article.

9

A new cholescintigraphic agent: ruthenium-97-DISIDA.

Zanzi I, Srivastava SC, Meinken GE, Robeson W, Mausner LF, Fairchild RG, Margouleff D. Zanzi I, et al. Among authors: srivastava sc. Int J Rad Appl Instrum B. 1989;16(4):397-403. doi: 10.1016/0883-2897(89)90107-4. Int J Rad Appl Instrum B. 1989. PMID: 2777581

10

Selection of radionuclides for radioimmunotherapy.

Mausner LF, Srivastava SC. Mausner LF, et al. Among authors: srivastava sc. Med Phys. 1993 Mar-Apr;20(2 Pt 2):503-9. doi: 10.1118/1.597045. Med Phys. 1993. PMID: 8492758 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters